SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Deciphera Announces Health Canada Authorization of QINLOCK for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor

Benzinga · -